Gyeong Je Cho

Gyeong Je Cho

Auto-generated profile, based on publicly available information

Gyeong Je Cho

Department of Dermatology, Busan Paik Hospital, College of Medicine, Inje University, Busan, Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Annals of Dermatology
Verified
Journal Article
Open access
PDF file
JSJung Eun Seol
Jung Eun Seol
GCGyeong Je Cho
Gyeong Je Cho
SJSeung Hee Jang
Seung Hee Jang
SASang Woo Ahn
Sang Woo Ahn
SHSeong Min Hong
Seong Min Hong
HKHyojin Kim
Hyojin Kim
Seol JE, et al. Ann Dermatol. 2024 Apr;36:e35. https://doi.org/10.5021/ad.23.067

1 January 2021 in Annals of Dermatology
Verified
Journal Article
Open access
JSJung Eun Seol
Jung Eun Seol
JKJong Uk Kim
Jong Uk Kim
SHSeong Min Hong
Seong Min Hong
GCGyeong Je Cho
Gyeong Je Cho
WJWoo Jung Jin
Woo Jung Jin
HKHyojin Kim
Hyojin Kim
Oral alitretinoin is effective in the treatment of chronic hand eczema (CHE), and ≥12 weeks of alitretinoin treatment has been shown to be effective in Korean patients. However, in the real world, a considerable number of patients discontinue alitretinoin, which leads to treatment failure. To evaluate the compliance rate of alitretinoin treatment and explore common reasons for poor compliance in patients with CHE in the real world. We retrospectively reviewed the electronic medical records of CHE patients treated with alitretinoin. We defined ‘poor-compliance’ as subjects who were treated with alitretinoin for <12 weeks and ‘good-compliance’ as subjects who were treated with alitretinoin for ≥12 weeks. We reviewed the demographics, dose, and duration of alitretinoin usage, efficacy, and reasons for poor compliance. A total of 137 subjects were enrolled, and 77 (56.2%) did not complete the 12-week treatment with alitretinoin. Among them, the non-improvement rate was significantly higher in the poor-compliance group than in the good-compliance group (p<0.01). The main reasons for the alitretinoin cessation in the poor-compliance group were insufficient response (40.8%), followed by high cost (34.7%), and adverse events (24.5%). Alitretinoin appears the preferred long-term treatment option for CHE. Although there are complaints about late efficacy, cost, and side effects, following proper explanation, these should not justify discontinuation. Physicians need to recognize the reasons for poor compliance with alitretinoin for each patient and suggest continuing alitretinoin for the successful treatment of CHE.

23 September 2020 in Australasian Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
JSJung Eun Seol
Jung Eun Seol
GCGyeong Je Cho
Gyeong Je Cho
SPSo Hee Park
So Hee Park
HKHyojin Kim
Hyojin Kim

1 January 2023 in Annals of Dermatology
Verified
Journal Article
Open access
PDF file
JSJung Eun Seol
Jung Eun Seol
SHSeong Min Hong
Seong Min Hong
SASang Woo Ahn
Sang Woo Ahn
JKJong Uk Kim
Jong Uk Kim
GCGyeong Je Cho
Gyeong Je Cho
HKHyojin Kim
Hyojin Kim
Seol JE, et al. Ann Dermatol. 2023 May;35:e48. https://doi.org/10.5021/ad.21a.028

20 April 2020 in Australasian Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
JSJung Eun Seol
Jung Eun Seol
GCGyeong Je Cho
Gyeong Je Cho
SPSo Hee Park
So Hee Park
HKHyojin Kim
Hyojin Kim

30 June 2019 in Korean Journal of Medical Mycology
Verified
Journal Article
Open access
HKHyojin Kim
Hyojin Kim
GCGyeong Je Cho
Gyeong Je Cho
JKJong Uk Kim
Jong Uk Kim
WJWoo Jung Jin
Woo Jung Jin
SPSo Hee Park
So Hee Park
JSJeong Hwan Shin
Jeong Hwan Shin
Purpureocillium is a genus of saprophytic fungi that is commonly found in soil or rotting material. Although rarely a pathogen in humans, it can cause serious infections in immunocompromized patients. An 85-year-old woman presented with a 2-week history of pruritic erythematous plaques with yellowish crusts on her right forearm and dorsal hand. Histopathological analysis identified fungal hyphae and spores in the dermis, and Purpureocillium lilacinum was identified through tissue culture, polymerase chain reaction, and DNA sequencing. The skin lesion barely responded to 4 weeks of itraconazole treatment but improved upon the addition of terbinafine. The skin lesion was completely cured after 12 weeks, with no recurrence to date. Here, we report a rare deep cutaneous fungal infection caused by P. lilacinum in an immunocompetent patient and postulate that, in this case, the patient's agricultural lifestyle increased the possibility of P. lilacinum infection.